Literature DB >> 19375167

Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability.

P Aguilar-Ramirez1, E S Reis, M P C Florido, A S Barbosa, C S Farah, B T Costa-Carvalho, L Isaac.   

Abstract

The deficiency of complement C5 is rare and frequently associated with severe and recurrent infections, especially caused by Neisseria spp. We observed the absence of component C5 in the serum of 3 siblings from a Brazilian family with history of consanguinity. The patients had suffered from recurrent episodes of meningitis and other less severe infections. Sera from these patients were unable to mediate hemolytic activity either by the classical or alternative pathways and presented extremely low levels of C5 protein (1.3, 0.9 and 1.0 microg/ml-normal range: 45-190 microg/ml). Hemolytic activity could be restored by the addition of purified C5 to deficient serum. Sequencing of sibling C5 cDNA revealed a homozygous 153 bp deletion that corresponds precisely to exon 30. The parents carried the same deletion but only in one allele. Sequencing of the corresponding region in the genomic DNA revealed a C to G substitution within intron 30 and, most significantly, the substitution of GAG(4028) for GAA(4028) at the 3' end of exon 30 which is most likely responsible for skipping of exon 30. The resulting in-frame deletion in the C5 mRNA codes for a mutant C5 protein lacking residues 1289-1339. These residues map to the CUB and C5d domains of the C5 alpha chain. This deletion is expected to produce a non-functional and unstable C5 protein which is more susceptible to degradation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19375167     DOI: 10.1016/j.molimm.2008.10.035

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

Review 1.  Disease-causing mutations in genes of the complement system.

Authors:  Søren E Degn; Jens C Jensenius; Steffen Thiel
Journal:  Am J Hum Genet       Date:  2011-06-10       Impact factor: 11.025

2.  Complement factor 5 (C5) p.A252T mutation is prevalent in, but not restricted to, sub-Saharan Africa: implications for the susceptibility to meningococcal disease.

Authors:  C Franco-Jarava; D Comas; A Orren; M Hernández-González; R Colobran
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

Review 3.  C5 complement deficiency in a Saudi family, molecular characterization of mutation and literature review.

Authors:  Rand Arnaout; Sahar Al Shorbaghi; Hasan Al Dhekri; Hamoud Al-Mousa; Abdulaziz Al Ghonaium; Bandar Al Saud; Saleh Al Muhsen; Lina Al Baik; Abbas Hawwari
Journal:  J Clin Immunol       Date:  2013-02-01       Impact factor: 8.317

4.  Novel Mutations Causing C5 Deficiency in Three North-African Families.

Authors:  Roger Colobran; Clara Franco-Jarava; Andrea Martín-Nalda; Neus Baena; Elisabeth Gabau; Natàlia Padilla; Xavier de la Cruz; Ricardo Pujol-Borrell; David Comas; Pere Soler-Palacín; Manuel Hernández-González
Journal:  J Clin Immunol       Date:  2016-03-30       Impact factor: 8.317

5.  Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice.

Authors:  Yahsou Delmas; Cécile Bordes; Chantal Loirat; Véronique Frémeaux-Bacchi; Christian Combe
Journal:  Clin Kidney J       Date:  2013-04

6.  Role of Murine Complement Component C5 in Acute in Vivo Infection by Pathogenic Leptospira interrogans.

Authors:  Íris A de Castro; Lorena Bavia; Tatiana R Fraga; Mariane T Amano; Leandro C D Breda; Adriana P Granados-Martinez; Ana M G da Silva; Silvio A Vasconcellos; Lourdes Isaac
Journal:  Front Cell Infect Microbiol       Date:  2018-03-08       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.